Putative Membrane Receptor for 1,25(OH) 2 Vitamin D 3 in Human Mineralized Tissues During Prenatal Development

Connective Tissue Research

Volumn 44, Issue 1, 2003, Pages 136-140

  Berdal, A ^a   Mesbah, M ^a   Papagerakis, P ^b   Nemere, I ^c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UTAH STATE UNIVERSITY   (United States)

Author keywords

Bone; Membrane Receptor; Nongenomic; Tooth; Vitamin D

Indexed keywords

CALCITRIOL; CALCITRIOL MEMBRANE ASSOCIATED RAPID RESPONSE STEROID BINDING PROTEIN; CELL NUCLEUS RECEPTOR; MEMBRANE RECEPTOR; STEROID BINDING PROTEIN; UNCLASSIFIED DRUG;

AMELOBLAST; ARTICLE; BONE CELL; CARTILAGE CELL; CELL POPULATION; CONTROLLED STUDY; CRANIOFACIAL MORPHOLOGY; DEVELOPMENTAL STAGE; EMBRYO; FETUS; HUMAN; IMMUNOLOCALIZATION; LIGAND BINDING; MINERALIZATION; MOLECULAR RECOGNITION; ODONTOBLAST; OSTEOBLAST; OSTEOCLAST; PRENATAL DEVELOPMENT; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SECRETORY CELL; SIGNAL TRANSDUCTION; TOOTH DEVELOPMENT;

GESTATIONAL AGE; HUMANS; IMMUNOENZYME TECHNIQUES; MANDIBLE; MEMBRANE PROTEINS; ORGANOGENESIS; RECEPTORS, CALCITRIOL; TOOTH CALCIFICATION; TOOTH GERM;

EID: 0037240793     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.1080/03008200390152223     Document Type: Article

References (27)

1. Norman, A.W., Song, X., Zanello, L., Bula, C., and Okamura, W.H. (1999). Rapid and genomic biological responses are mediated by different shapes of the agonist steroid hormone, 1alpha,25(OH)2 vitamin D3. Steroids 64: 120 – 128.
2. Bouillon, R., Garmyn, M., Verstuyf, A., Segaert, S., Casteels, K., and Mathieu, C. (1995). Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs. Eur. J. Endocrinol. 133: 7 – 16.
3. Berdal, A., Hotton, D., Pike, J.W., Mathieu, H., and Dupret, J.M. (1993). Cell- and stage-specific expression of vitamin D receptor and calbindin genes in rat incisor: Regulation by 1,25-dihydroxyvitamin D3. Dev. Biol. 155: 172 – 181.
4. Nemere, I., Dormanen, M.C., Hammond, M.W., Okamura, W.H., and Norman, A.W. (1994). Identification of a specific binding protein for 1 alpha,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J. Biol. Chem. 269: 23750 – 23756.
5. Nemere, I., and Farach-Carson, M.C. (1998). Membrane receptors for steroid hormones: A case for specific cell surface binding sites for vitamin D metabolites and estrogens. Biochem. Biophys. Res. Commun. 248: 443 – 452.
6. Boyan, B.D., Sylvia, V.L., Dean, D.D., Pedrozo, H., Del Toro, F., Nemere, I., Posner, G.H., and Schwartz, Z. (1999). 1,25-(OH)2D3 modulates growth plate chondrocytes via membrane receptor-mediated protein kinase C by a mechanism that involves changes in phospholipid metabolism and the action of arachidonic acid and PGE2. Steroids 64: 129 – 165.
7. Mesbah, M., Nemere, I., Papagerakis, P., Nefussi, J.R., Orestes-Cardoso, S., Nessmann, C., and Berdal, A. (2002). Expression of a 1,25(OH)2 vi- tamin D3 membrane-associated, rapid-response steroid-binding (1,25D3- MARRS) protein during human tooth and bone development and biomin- eralization. J. Bone Min. Res. (in press).
8. Bailleul-Forestier, I., Davideau, J.L., Papagerakis, P., Noble, I., Nessmann, C., Peuchmaur, M., and Berdal, A. (1996). Immunolocalization of vitamin D receptor and calbindin-D28k in human tooth germ. Pediatr. Res. 39: 636 – 642.
9. Van den Boogaard, M.J., Dorland, M., Beemer, F.A., and van Amstel, H.K. (2000). MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans. Nat. Genet. 24: 342 – 345.
10. Yoshizawa, T., Handa, Y., Uematsu, Y., Takeda, S., Sekine, K., Yoshi- hara, Y., Kawakami, T., Arioka, K., Sato, H., Uchiyama, Y., Masushige, S., Fukamizu, A., Matsumoto, T., and Kato, S. (1997). Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 16: 391 – 396.
11. Berdal, A., Balmain, N., Cuisinier-Gleizes, P., and Mathieu, H. (1987). Histology and microradiography of early post-natal molar tooth develop- ment in vitamin-D deficient rats. Arch. Oral Biol. 32: 493 – 502.
12. Li, Y.C., Amling, M., Pirro, A.E., Priemel, M., Meuse, J., Baron, R., Delling, G., and Demay, M.B. (1998). Normalization of mineral ion home- ostasis by dietary means prevents hyperparathyroidism, rickets, and osteo- malacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinol- ogy 139: 4391 – 4396.
13. Kato, S., Takeyama, K., Kitanaka, S., Murayama, A., Sekine, K., and Yoshizawa, T. (1999). In vivo function of VDR in gene expression-VDR knock-out mice. J. Steroid Biochem. Mol. Biol. 69: 247 – 251.
14. Takano, Y., Sakai, H., Baba, O., and Terashima, T. (2000). Differential involvement of matrix vesicles during the initial and appositional miner- alization processes in bone, dentin, and cementum. Bone 26: 333 – 342.
15. Gibson, C.W. (1999). Regulation of amelogenin gene expression. Crit.Rev. Eukaryot. Gene. Expr. 9: 45 – 57.
16. Pedrozo, H.A., Schwartz, Z., Rimes, S., Sylvia, V.L., Nemere, I., Pos- ner, G.H., Dean, D.D., and Boyan, B.D. (1999). Physiological importance of the 1,25(OH)2D3 membrane receptor and evidence for a membrane receptor specific for24,25(OH)2D3. J. Bone Miner. Res. 14: 856 – 867.
17. Takagi, M., Parmley, R.T., and Denys, F.R. (1981). Ultrastructural cy- tochemistry and radioautography of complex carbohydrates in secretory granules of epiphyseal chondrocytes. Lab. Invest. 44: 116 – 126.
18. Cowles, E.A., DeRome, M.E., Pastizzo, G., Brailey, L.L., and Gronowicz, G.A. (1998). Mineralization and the expression of matrix proteins during in vivo bone development. Calcif. Tiss. Int. 62: 74 – 82.
19. Franceschi, R.T. (1999). The developmental control of osteoblast-specific gene expression: Role of specific transcription factors and the extracellular matrix environment. Crit. Rev. Oral Biol. Med. 10: 40 – 57.
20. Sommer, B., Bickel, M., Hofstetter, W., and Wetterwald, A. (1996). Ex- pression of matrix proteins during the development of mineralized tissues. Bone 19: 371 – 380.
21. Schwartz, Z., Bonewald, L.F., Caulfield, K., Brooks, B., and Boyan, B.D. (1993). Direct effects of transforming growth factor-beta on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific man- ner. Endocrinology 132: 1544 – 1552.
22. Schwartz, Z., Swain, L., Sela, J., Gross, U., Amir, D., Kohavi, D., Muller- Mai, C., and Boyan, B. (1992). In vivo regulation of matrix vesicle concen- tration and enzyme activity during primary bone formation. Bone Miner. 17: 134 – 142.
23. Swain, L.D., Schwartz, Z., Caulfield, K., Brooks, B.P., and Boyan, B.D. (1993). Nongenomic regulation of chondrocyte membrane fluidity by 1,25-(OH)2D3 and 24,25-(OH)2D3 is dependent on cell maturation. Bone 14: 609 – 617.
24. Schwartz, Z., Langston, G.G., Swain, L.D., and Boyan, B.D. (1991). In- hibition of 1,25-(OH)2D3- and 24,25-(OH)2D3-dependent stimulation of alkaline phosphatase activity by A23187 suggests a role for calcium in the mechanism of vitamin D regulation of chondrocyte cultures. J. Bone Miner. Res. 6: 709 – 718.
25. Sylvia, V.L., Schwartz, Z., Schuman, L., Morgan, R.T., Mackey, S., Gomez, R., and Boyan, B.D. (1993). Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures. J. Cell Physiol. 157: 271 – 279.
26. Sela, J., Schwartz, Z., Amir, D., Swain, L.D., and Boyan, B.D. (1992). The effect of bone injury on extracellular matrix vesicle proliferation and mineral formation. Bone Miner. 17: 163 – 170.
27. Davideau, J.L., Papagerakis, P., Hotton, D., Lezot, F., and Berdal, A. (1996). In situ investigation of vitamin D receptor, alkaline phosphatase, and osteocalcin gene expression in oro-facial mineralized tissues. En- docrinology 137: 3577 – 3585.